A yeast-based model of alpha-synucleinopathy identifies compounds with therapeutic potential

Gerard Griffioen1, Hein Duhamel, Nele Van Damme

  • 1N.V. reMYND, Minderbroedersstraat 12, B-3000 Leuven, Belgium. gerard.griffioen@remyund.be